SCHEMBL23680936

SCHEMBL23680936

C[C@H](NC(=O)OC(C)(C)C)C(=O)OC1CC1c1ccc(C(C)(C)C)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.40
HPGD P15428 2/20 0.40
MAPT P10636 2/20 0.40
GLA P06280 1/20 0.40
GAA P10253 1/20 0.40
KDM1A O60341 2/20 0.40
SLC6A2 P23975 1/20 0.39
MAOB P27338 2/20 0.38
MAOA P21397 1/20 0.38
TLR2 O60603 2/20 0.37
TLR1 Q15399 2/20 0.37
EPHX2 P34913 1/20 0.37
TRPV1 Q8NER1 2/20 0.35
KLK7 P49862 2/20 0.35
KLK5 Q9Y337 2/20 0.35
HRH2 P25021 1/20 0.35
HRH1 P35367 1/20 0.35
KMT2A Q03164 1/20 0.34
HSD11B1 P28845 1/20 0.34
HTT P42858 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23680934 0.79 SLC6A2 (0.42) MAPTSLC6A2MAOATRPV1KMT2A
Hydrochloric Acid SCHEMBL22436644 0.78 SLC6A2 (0.41) MAPTSLC6A2MAOATRPV1HTT
Hydrochloric Acid SCHEMBL22436645 0.78 SLC6A2 (0.41) MAPTSLC6A2MAOATRPV1HTT
SCHEMBL25343021 0.76 CACNA1B (0.46) KDM4EHPGDMAPTGLAGAA
SCHEMBL29501742 0.74 HTT (0.35) HPGDMAPTGAASLC6A2TRPV1
SCHEMBL29047772 0.74 HTT (0.35) HPGDMAPTGAASLC6A2TRPV1
SCHEMBL28829894 0.74 SLC6A2 (0.47) MAPTKDM1ASLC6A2MAOATRPV1
SCHEMBL24298844 0.72 HDAC1 (0.45) KDM4EHPGDMAPTGLAGAA
SCHEMBL24298843 0.72 HDAC1 (0.45) KDM4EHPGDMAPTGLAGAA
SCHEMBL17902291 0.71 NR1H4 (0.42) KDM4EHPGDMAPTGLAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111344279-B Microbiocidal picolinamide derivatives 先正达参股股份有限公司 2023-07-07 CN disclosed
EP-3710429-B1 MICROBIOCIDAL PICOLINAMIDE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2023-04-05 EP disclosed
US-11291205-B2 Microbiocidal picolinamide derivatives SYNGENTA PARTICIPATIONS AG (CH) 2022-04-05 US disclosed
US-20210227826-A1 Microbiocidal Picolinamide Derivatives SYNGENTA PARTICIPATIONS AG (CH) 2021-07-29 US disclosed
CN-111344279-A Microbicidal picolinamide derivatives 先正达参股股份有限公司 2020-06-26 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11291205-B2 Microbiocidal picolinamide derivatives CASP2, CASP1, MSR1 KDM4E 4007/4885HPGD 754/4885MAPT 3159/4885
US-20210227826-A1 Microbiocidal Picolinamide Derivatives CASP2, CASP1, MSR1 KDM4E 4007/4885HPGD 754/4885MAPT 3159/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.